JP2022523704A5 - - Google Patents
Info
- Publication number
- JP2022523704A5 JP2022523704A5 JP2021543509A JP2021543509A JP2022523704A5 JP 2022523704 A5 JP2022523704 A5 JP 2022523704A5 JP 2021543509 A JP2021543509 A JP 2021543509A JP 2021543509 A JP2021543509 A JP 2021543509A JP 2022523704 A5 JP2022523704 A5 JP 2022523704A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- pharmaceutical composition
- composition according
- fatty acid
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019073112 | 2019-01-25 | ||
| CNPCT/CN2019/073112 | 2019-01-25 | ||
| PCT/CN2020/073099 WO2020151633A1 (en) | 2019-01-25 | 2020-01-20 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523704A JP2022523704A (ja) | 2022-04-26 |
| JP2022523704A5 true JP2022523704A5 (cg-RX-API-DMAC7.html) | 2023-01-31 |
Family
ID=71736646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543509A Pending JP2022523704A (ja) | 2019-01-25 | 2020-01-20 | 医薬組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220193095A9 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3914234A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022523704A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113473974A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020151633A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114026106B (zh) | 2019-03-06 | 2025-01-21 | 普洛拉治疗公司 | 阿比特龙前药 |
| CN114762693A (zh) * | 2020-12-31 | 2022-07-19 | 成都海博为药业有限公司 | 一种载药量高的阿比特龙药物组合物及其制备方法及用途 |
| CN117120034A (zh) | 2021-02-15 | 2023-11-24 | 普洛佩拉治疗公司 | 阿比特龙前药 |
| KR20230165280A (ko) * | 2021-04-01 | 2023-12-05 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 제약 제제에서 음이온 킬레이트화제로서의 인지질 |
| WO2023038933A1 (en) * | 2021-09-08 | 2023-03-16 | Propella Therapeutics, Inc. | Oral abiraterone formulations |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2677613B2 (ja) * | 1988-06-24 | 1997-11-17 | エーザイ株式会社 | ビタミンe又はその誘導体の吸収促進組成物 |
| US20030149061A1 (en) * | 2000-04-04 | 2003-08-07 | Yoshitaka Nishihara | Oily compositions containing highly fat-soluble drugs |
| CA2626579A1 (en) * | 2005-10-25 | 2007-05-03 | Abbott Laboratories | Formulation comprising a drug of low water solubility and method of use thereof |
| US20080145411A1 (en) * | 2006-10-06 | 2008-06-19 | Kaneka Corporation | Composition of high absorbability for oral administration comprising oxidized coenzyme q10 |
| US20110160168A1 (en) * | 2009-12-31 | 2011-06-30 | Differential Drug Development Associates, Llc | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| US20130303495A1 (en) * | 2009-12-31 | 2013-11-14 | Sov Therapeutics | Emulsion formulations |
| GB2488788B (en) * | 2011-03-07 | 2013-07-10 | Natco Pharma Ltd | Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response |
| CN103169712B (zh) * | 2011-12-20 | 2017-10-27 | 重庆华邦制药有限公司 | 提高生物利用度的度他雄胺制剂及其制备方法 |
| GB201207886D0 (en) * | 2012-05-04 | 2012-06-20 | Jagotec Ag | Improvements in or relating to organic compounds |
| KR20140043579A (ko) * | 2012-09-24 | 2014-04-10 | 한국콜마주식회사 | 무복계면 디클로페낙나트륨 및 그 제조방법 |
| TWI686212B (zh) * | 2013-03-15 | 2020-03-01 | 阿聯商太陽法瑪全球有限公司 | 醋酸阿比特龍配方 |
| WO2016044701A1 (en) * | 2014-09-18 | 2016-03-24 | Iceutica Inc. | Abiraterone acetate formulation and methods of use |
| WO2017037647A1 (en) * | 2015-09-02 | 2017-03-09 | Leiutis Pharmaceuticals Pvt Ltd | Stable pharmaceutical compositions of abiraterone |
| CN105055314A (zh) * | 2015-09-28 | 2015-11-18 | 杭州安德科技有限公司 | 一种阿比特龙的口腔喷雾剂及其使用和制备方法 |
| CA2922959C (en) * | 2016-03-03 | 2018-01-02 | Pankaj Modi | Orally administrable composition |
-
2020
- 2020-01-20 JP JP2021543509A patent/JP2022523704A/ja active Pending
- 2020-01-20 WO PCT/CN2020/073099 patent/WO2020151633A1/en not_active Ceased
- 2020-01-20 EP EP20745571.8A patent/EP3914234A4/en not_active Withdrawn
- 2020-01-20 CN CN202080010385.3A patent/CN113473974A/zh active Pending
- 2020-03-11 US US16/815,569 patent/US20220193095A9/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250099489A1 (en) | Abiraterone prodrugs | |
| US10286077B2 (en) | Steroid hormone compositions in medium chain oils | |
| US7138389B2 (en) | Oral androgen therapy using modulators of testosterone bioavailability | |
| JP2022523704A (ja) | 医薬組成物 | |
| US20040014734A1 (en) | Farnesoid X-activated receptor agonists | |
| US20030083231A1 (en) | Blood cell deficiency treatment method | |
| BR112012025961B1 (pt) | Composição farmacêutica oral | |
| AU2008201188A1 (en) | Use of certain steroids for treatment of blood cell deficiencies | |
| JP2010501575A (ja) | 癌を治療するための方法及び組成物 | |
| WO2017173191A1 (en) | Steroid hormone compositions in medium chain oils | |
| SE463074B (sv) | Anvaendning av aromatashaemmare och antiandrogener foer framstaellning av laekemedel foer profylax och terapi av benign prostatahyperplasi | |
| AU2002244247A1 (en) | Use of certain steroids for treatment of blood cell deficiencies | |
| JP2011503075A5 (cg-RX-API-DMAC7.html) | ||
| CN111432805B (zh) | 3α-乙炔基-3β-羟基雄甾烷-17-酮肟的药物制剂 | |
| JP2025504430A5 (cg-RX-API-DMAC7.html) | ||
| KR102238478B1 (ko) | 구강 전달용 지방균형잡힌 장쇄 테스토스테론 에스테르 | |
| JP4519640B2 (ja) | 非ペプチドレニン阻害薬及び界面活性剤を含有する医薬製剤 | |
| JP2002539135A5 (cg-RX-API-DMAC7.html) | ||
| JP2003160496A (ja) | グリチルリチン経口投与剤 | |
| HK40130201A (en) | Abiraterone prodrugs | |
| HK40129794A (zh) | 阿比特龙前药 | |
| HK40065545B (en) | Abiraterone prodrugs | |
| JPH09511251A (ja) | ステロイド性5−アルファ−レダクターゼ阻害剤での心臓血管系疾患の治療 |